Cefquinome Norbrook DC, 150 mg Intramammary Ointment for Dry Cows

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

Cefquinome

Mevcut itibaren:

Norbrook Laboratories Limited

ATC kodu:

QJ51DE90

INN (International Adı):

Cefquinome

Doz:

150 mg/syringe

Farmasötik formu:

Intramammary ointment

Reçete türü:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapötik grubu:

Cattle

Terapötik alanı:

cefquinome

Terapötik endikasyonlar:

Antibacterial

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2014-09-26

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cefquinome Norbrook DC, 150 mg Intramammary Ointment for Dry Cows.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary ointment.
Homogenous off-white oily ointment.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (Dry cows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of subclinical mastitis at drying off and the
prevention of new bacterial infections of the udder during
the dry period in the dairy cow caused by the following cefquinome
sensitive organisms:_ Streptococcus uberis,_
_Streptococcus dysgalactiae, Streptococcus agalactiae, Staphylococcus
aureus,_ coagulase negative staphylococci.
4.3 CONTRAINDICATIONS
Do not use in cows with clinical mastitis.
Do not use in case of hypersensitivity to cephalosporin antibiotics or
other
-lactam antibiotics, or to any of the
excipients.
See section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each 3 g pre-filled syringe contains:
ACTIVE SUBSTANCE:
Cefquinome:
150 mg
(as cefquinome sulfate)
For the full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_5_
_5_
_6_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal.
If